Naproxen Suspension
Product Images NDC 42192-619
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Naproxen (NDC 42192-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Acella Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Ndc – 42192-619-16 Naproxen (naproxen Suspension) 125 mg/5 mL (contains 39 mg Sodium) 473 mL Bottle Rx Only (Naproxen Label)
This is a description of Naproxen oral suspension, USP with a dosage of 125 mg/5 mL. The medication should be dispensed in a light-resistant container by the pharmacist, along with a medication guide, for oral administration only. The non-coating area measures 3.8125" X 1.6819", and the medication should not be used if the tamper-evident seal is separated or missing. It is advisable to store the medication at 25°C (77°F), with allowed excursions between 10 15°C - 30°C (59°F - 86°F), and avoid heat above 40°C (104°F). To obtain dosage recommendations and other important information, the accompanying prescription information should be consulted. The product is made in Canada and distributed by Acella Pharmaceuticals, LLC, Alpharetta, GA 30005. The product label includes the manufacturer code, product code, and NDC number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.